HRP20041160A2 - Novel combination for the treatment of airway disorders - Google Patents

Novel combination for the treatment of airway disorders

Info

Publication number
HRP20041160A2
HRP20041160A2 HR20041160A HRP20041160A HRP20041160A2 HR P20041160 A2 HRP20041160 A2 HR P20041160A2 HR 20041160 A HR20041160 A HR 20041160A HR P20041160 A HRP20041160 A HR P20041160A HR P20041160 A2 HRP20041160 A2 HR P20041160A2
Authority
HR
Croatia
Prior art keywords
treatment
novel combination
airway disorders
airway
disorders
Prior art date
Application number
HR20041160A
Other languages
English (en)
Inventor
Kromer Wolfgang
Hanauer Guido
Simon Wolfgang-Alexander
Postius Stefan
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of HRP20041160A2 publication Critical patent/HRP20041160A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20041160A 2002-05-07 2003-05-03 Novel combination for the treatment of airway disorders HRP20041160A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02010305 2002-05-07
PCT/EP2003/004653 WO2003094967A2 (en) 2002-05-07 2003-05-03 New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders

Publications (1)

Publication Number Publication Date
HRP20041160A2 true HRP20041160A2 (en) 2005-08-31

Family

ID=29414673

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20041160A HRP20041160A2 (en) 2002-05-07 2003-05-03 Novel combination for the treatment of airway disorders

Country Status (17)

Country Link
US (1) US20050222193A1 (sr)
EP (1) EP1506016A2 (sr)
JP (1) JP2005528418A (sr)
KR (1) KR20050007476A (sr)
CN (1) CN1652822A (sr)
AU (1) AU2003227710A1 (sr)
BR (1) BR0309808A (sr)
CA (1) CA2484272A1 (sr)
EA (1) EA200401454A1 (sr)
HR (1) HRP20041160A2 (sr)
IL (1) IL164755A0 (sr)
MX (1) MXPA04011018A (sr)
NO (1) NO20045343L (sr)
PL (1) PL373287A1 (sr)
RS (1) RS95304A (sr)
WO (1) WO2003094967A2 (sr)
ZA (1) ZA200407896B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003043614A2 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
EP1761157A1 (en) * 2004-04-30 2007-03-14 ALTANA Pharma AG Method of classifying gerd
AU2005291302A1 (en) * 2004-10-05 2006-04-13 Altana Pharma Ag Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
ES2677668T3 (es) 2010-11-16 2018-08-06 Texas Heart Institute Agonistas que mejoran la unión de células que expresan integrina a receptores de integrina
KR101873530B1 (ko) * 2012-04-10 2018-07-02 삼성전자주식회사 모바일 기기, 모바일 기기의 입력 처리 방법, 및 모바일 기기를 이용한 전자 결제 방법
JO3737B1 (ar) * 2015-07-21 2021-01-31 Athenex Therapeutics Ltd تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
CZ290266B6 (cs) * 1993-07-02 2002-06-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituované benzamidy, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
NZ298853A (en) * 1995-01-27 1998-07-28 Rhone Poulenc Rorer Ltd 5-[2-cyano-phenoxy]-2-phenyl-acetic acid derivatives
ATE301457T1 (de) * 1995-06-12 2005-08-15 Searle & Co Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
US5840917A (en) * 1995-09-26 1998-11-24 Takeda Chemical Industries, Ltd. Phosphorylamides, their preparation and use
US6380222B2 (en) * 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
SE9603725D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New teatment
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
ES2232015T3 (es) * 1997-07-25 2005-05-16 Altana Pharma Ag Inhibidor de las bombas de protones en combinacion terapeutica con sustancias antibacterianas.
US6060472A (en) * 1998-04-06 2000-05-09 Apotex Inc. Thiadiazole compounds useful as inhibitors of H+ /K+ atpase
CA2341488A1 (en) * 1998-08-26 2000-03-09 Smithkline Beecham Corporation Therapies for treating pulmonary diseases
WO2000017200A1 (en) * 1998-09-23 2000-03-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
GB9911017D0 (en) * 1999-05-13 1999-07-14 Zeneca Ltd Pharmaceutical compositions
JP2003528878A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト イミダゾピリジン誘導体のプロドラッグ
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6528527B2 (en) * 2000-11-07 2003-03-04 Merck & Co., Inc. Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist
WO2003043614A2 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders

Also Published As

Publication number Publication date
IL164755A0 (en) 2005-12-18
WO2003094967A2 (en) 2003-11-20
WO2003094967A3 (en) 2004-04-01
CA2484272A1 (en) 2003-11-20
MXPA04011018A (es) 2005-01-25
ZA200407896B (en) 2006-06-28
EA200401454A1 (ru) 2005-06-30
AU2003227710A1 (en) 2003-11-11
NO20045343L (no) 2004-12-06
CN1652822A (zh) 2005-08-10
JP2005528418A (ja) 2005-09-22
PL373287A1 (en) 2005-08-22
RS95304A (sr) 2006-12-15
US20050222193A1 (en) 2005-10-06
BR0309808A (pt) 2005-03-01
KR20050007476A (ko) 2005-01-18
EP1506016A2 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
PL372425A1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
AU2003286567A8 (en) Methods for the treatment of skin disorders
IL209842A0 (en) Compounds for the treatment of metabolic disorders
PT1656346E (pt) Indole 1,2,3,4-tetrassubstituído para o tratamento de doenças respiratórias
ZA200401004B (en) Combination for the treatment of inflammatory disorders
SI1556342T1 (sl) Fenetanolaminski derivat za zdravljenje respiratornih bolezni
AU2003233583A1 (en) Oral lactoferrin in the treatment of respiratory disorders
IL169332A0 (en) Compounds for the treatment of metabolic disorders
PL378108A1 (pl) Leczenie łączone do terapii zapalnych zaburzeń immunologicznych
AU2003274342A8 (en) Compositions for the treatment of autoimmune disorders
AU2003228819A8 (en) Combinations for the treatment of inflammatory skin disorders
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
SI1530466T1 (sl) Uporaba nintedaniba za zdravljenje pljučne fibroze
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
IL163871A0 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
IL168065A0 (en) Herbal medicine containing cyclodextrins for the treatment of ear disorders
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003294100A8 (en) Use of hyaluronic acid for respiratory disorders or the upper airways
ZA200505996B (en) Combination therapy for the treatment of immunoinflammatory disorders
HRP20041159A2 (en) Combination for the treatment of airway disorders
GB2388027B (en) Use of palatinose for the treatment of mental stress
GB0201025D0 (en) The treatment of degenerative diseases
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU2003243214A1 (en) Salts of bis-arylsulfones for the treatment of cns disorders

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080429

Year of fee payment: 6

OBST Application withdrawn